MilliporeSigma has announced a strategic partnership with Promega Corporation to advance the development of innovative drug discovery technologies. The collaboration aims to enhance the accessibility of...
MilliporeSigma, the life science division of Merck KGaA, Darmstadt, Germany, has announced a partnership with Promega Corporation to co-develop innovative technologies aimed at advancing drug screening...
Merck KGaA has received approval from the European Commission for its innovative therapy, Ezmekly, aimed at treating symptomatic, inoperable plexiform neurofibromas in patients diagnosed with neurofibromatosis...